Stem cell transplant for blood cancer: quality of life and costs
Part of Blood & lymphatic clinical trials.
This study looks at how having a stem cell transplant (a treatment that replaces your bone marrow with healthy donor cells) affects your quality of life and finances. It also explores the reasons why people on Reunion Island choose to have or not have this transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer, such as acute leukemia, lymphoma, Hodgkin's disease, or myelodysplastic syndrome
- You are being considered for a stem cell transplant (bone marrow transplant) that would be done in mainland France
- You live on Reunion Island
- You are 18 years or older
- You are able to fill out a questionnaire
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who have had or are planning to have a stem cell transplant. It helps doctors learn more about long-term outcomes and improve care for future patients.
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
This trial tests a special type of stem cell transplant that may help people with certain blood cancers or bone marrow diseases. The transplant uses donor stem cells that are specially selected to reduce the risk of complications. It might be an option for patients who need a transplant to treat their condition.
This study looks at how patients feel after receiving CAR-T therapy or a stem cell transplant for blood cancers. Your answers to a questionnaire will help doctors understand your experience and improve care.
This trial tests a specialized donor stem cell transplant to treat high-risk problems in the blood and bone marrow, including some cancers and non-cancers. It may help by using donor immune cells designed to better control the disease after transplant.
This study looks at using stem cells from a donor's bone marrow or blood to treat blood cancers like leukemia or lymphoma. It compares transplants from partially matched donors with fully matched donors to see how well they work.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.